Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

'Allocation concealment': the evolution and adoption of a methodological term.

Schulz KF, Chalmers I, Altman DG, Grimes DA, Moher D, Hayes RJ.

J R Soc Med. 2018 Jun;111(6):216-224. doi: 10.1177/0141076818776604. No abstract available.

2.

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.

Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P; CONSORT NPT Group.

Ann Intern Med. 2017 Jul 4;167(1):40-47. doi: 10.7326/M17-0046. Epub 2017 Jun 20.

PMID:
28630973
3.

Harms of outcome switching in reports of randomised trials: CONSORT perspective.

Altman DG, Moher D, Schulz KF.

BMJ. 2017 Feb 14;356:j396. doi: 10.1136/bmj.j396. No abstract available.

PMID:
28196813
4.

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krle A-Jerić K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D.

Rev Panam Salud Publica. 2015 Dec;38(6):506-14.

5.

Update on the endorsement of CONSORT by high impact factor journals: a survey of journal "Instructions to Authors" in 2014.

Shamseer L, Hopewell S, Altman DG, Moher D, Schulz KF.

Trials. 2016 Jun 24;17(1):301. doi: 10.1186/s13063-016-1408-z.

6.

Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review.

Stevens A, Shamseer L, Weinstein E, Yazdi F, Turner L, Thielman J, Altman DG, Hirst A, Hoey J, Palepu A, Schulz KF, Moher D.

BMJ. 2014 Jun 25;348:g3804. doi: 10.1136/bmj.g3804. Review.

7.

Steroidal contraceptives: effect on bone fractures in women.

Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M.

Cochrane Database Syst Rev. 2014 Jun 24;(6):CD006033. doi: 10.1002/14651858.CD006033.pub5. Review.

PMID:
24960023
8.

Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.

Lopez LM, Grimes DA, Schulz KF.

Cochrane Database Syst Rev. 2014 Apr 30;(4):CD006133. Review.

PMID:
24788670
9.

Oral contraceptives for functional ovarian cysts.

Grimes DA, Jones LB, Lopez LM, Schulz KF.

Cochrane Database Syst Rev. 2014 Apr 29;(4):CD006134. doi: 10.1002/14651858.CD006134.pub5. Review.

PMID:
24782304
10.

Combination contraceptives: effects on weight.

Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM.

Cochrane Database Syst Rev. 2014 Jan 29;(1):CD003987. doi: 10.1002/14651858.CD003987.pub5. Review.

PMID:
24477630
11.

Increasing value and reducing waste in research design, conduct, and analysis.

Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R.

Lancet. 2014 Jan 11;383(9912):166-75. doi: 10.1016/S0140-6736(13)62227-8. Epub 2014 Jan 8.

12.

Spermicide used alone for contraception.

Grimes DA, Lopez LM, Raymond EG, Halpern V, Nanda K, Schulz KF.

Cochrane Database Syst Rev. 2013 Dec 5;(12):CD005218. doi: 10.1002/14651858.CD005218.pub4. Review.

PMID:
24307556
13.

Get in the spirit with SPIRIT 2013: protocol content guideline for clinical trials.

Schulz KF, Grimes DA.

Contraception. 2013 Dec;88(6):676-7. doi: 10.1016/j.contraception.2013.10.002. Epub 2013 Oct 18. No abstract available.

PMID:
24230918
14.

Spermicide used alone for contraception.

Grimes DA, Lopez LM, Raymond EG, Halpern V, Nanda K, Schulz KF.

Cochrane Database Syst Rev. 2013 Sep 30;(9):CD005218. doi: 10.1002/14651858.CD005218.pub3. Epub 2013 Sep 30. Review. Update in: Cochrane Database Syst Rev. 2013;(12):CD005218.

PMID:
24085632
15.

20 µg versus >20 µg estrogen combined oral contraceptives for contraception.

Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF.

Cochrane Database Syst Rev. 2013 Aug 1;(8):CD003989. doi: 10.1002/14651858.CD003989.pub5. Review.

PMID:
23904209
16.

Sponge versus diaphragm for contraception.

Kuyoh MA, Toroitich-Ruto C, Grimes DA, Schulz KF, Gallo MF, Lopez LM.

Cochrane Database Syst Rev. 2002 Jul 22;(5):CD003172. doi: 10.1002/14651858.CD003172. Review.

PMID:
23866318
17.

Combination injectable contraceptives for contraception.

Gallo MF, Grimes DA, Lopez LM, Schulz KF, d'Arcangues C.

Cochrane Database Syst Rev. 2013;3:CD004568. Review.

PMID:
23641480
18.

Strategies for communicating contraceptive effectiveness.

Lopez LM, Steiner M, Grimes DA, Hilgenberg D, Schulz KF.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD006964. doi: 10.1002/14651858.CD006964.pub3. Review.

PMID:
23633337
19.

Skin patch and vaginal ring versus combined oral contraceptives for contraception.

Lopez LM, Grimes DA, Gallo MF, Stockton LL, Schulz KF.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD003552. doi: 10.1002/14651858.CD003552.pub4. Review.

PMID:
23633314
20.

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D.

BMJ. 2013 Jan 8;346:e7586. doi: 10.1136/bmj.e7586.

21.

SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D.

Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.

22.

Immediate start of hormonal contraceptives for contraception.

Lopez LM, Newmann SJ, Grimes DA, Nanda K, Schulz KF.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD006260. doi: 10.1002/14651858.CD006260.pub3. Review.

PMID:
23235628
23.

Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review.

Turner L, Shamseer L, Altman DG, Schulz KF, Moher D.

Syst Rev. 2012 Nov 29;1:60. doi: 10.1186/2046-4053-1-60. Review.

24.

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, Dias S, Schulz KF, Plint AC, Moher D.

Cochrane Database Syst Rev. 2012 Nov 14;11:MR000030. doi: 10.1002/14651858.MR000030.pub2. Review.

PMID:
23152285
25.

False alarms and pseudo-epidemics: the limitations of observational epidemiology.

Grimes DA, Schulz KF.

Obstet Gynecol. 2012 Oct;120(4):920-7.

PMID:
22996110
26.

Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.

Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JP, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JA.

Ann Intern Med. 2012 Sep 18;157(6):429-38.

PMID:
22945832
27.

Improving the reporting of randomised trials: the CONSORT Statement and beyond.

Altman DG, Moher D, Schulz KF.

Stat Med. 2012 Nov 10;31(25):2985-97. doi: 10.1002/sim.5402. Epub 2012 Aug 18.

PMID:
22903776
28.

Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.

Lopez LM, Grimes DA, Schulz KF.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006133. doi: 10.1002/14651858.CD006133.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;(4):CD006133.

PMID:
22513937
29.

Steroid hormones for contraception in men.

Grimes DA, Lopez LM, Gallo MF, Halpern V, Nanda K, Schulz KF.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD004316. doi: 10.1002/14651858.CD004316.pub4. Review.

PMID:
22419294
30.

Triphasic versus monophasic oral contraceptives for contraception.

Van Vliet HA, Grimes DA, Lopez LM, Schulz KF, Helmerhorst FM.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD003553. doi: 10.1002/14651858.CD003553.pub3. Review.

PMID:
22071807
31.

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG; CONSORT.

Int J Surg. 2012;10(1):28-55. doi: 10.1016/j.ijsu.2011.10.001. Epub 2011 Oct 12. Review.

32.

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Schulz KF, Altman DG, Moher D; CONSORT Group.

Int J Surg. 2011;9(8):672-7. doi: 10.1016/j.ijsu.2011.09.004. Epub 2011 Oct 13. No abstract available.

33.

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group.

BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928. No abstract available.

34.

Oral contraceptives for functional ovarian cysts.

Grimes DA, Jones LB, Lopez LM, Schulz KF.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD006134. doi: 10.1002/14651858.CD006134.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD006134.

PMID:
21901701
35.

Combination contraceptives: effects on weight.

Gallo MF, Lopez LM, Grimes DA, Schulz KF, Helmerhorst FM.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD003987. doi: 10.1002/14651858.CD003987.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003987.

PMID:
21901687
36.

Steroidal contraceptives: effect on bone fractures in women.

Lopez LM, Grimes DA, Schulz KF, Curtis KM.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD006033. doi: 10.1002/14651858.CD006033.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;6:CD006033.

PMID:
21735401
37.

The methodology for developing a prospective meta-analysis in the family planning community.

Turok DK, Espey E, Edelman AB, Lotke PS, Lathrop EH, Teal SB, Jacobson JC, Simonsen SE, Schulz KF.

Trials. 2011 Apr 29;12:104. doi: 10.1186/1745-6215-12-104.

38.

Resources for authors of reports of randomized trials: harnessing the wisdom of authors, editors, and readers.

Moher D, Hopewell S, Schulz KF, Altman DG.

Trials. 2011 Apr 19;12:98. doi: 10.1186/1745-6215-12-98.

39.

Development of a combined database for meta-epidemiological research.

Savović J, Harris RJ, Wood L, Beynon R, Altman D, Als-Nielsen B, Balk EM, Deeks J, Gluud LL, Gluud C, Loannidis JP, Jűni P, Moher D, Pildal J, Schulz KF, Sterne JA.

Res Synth Methods. 2011 Mar;2(1):78. doi: 10.1002/jrsm.33. Epub 2011 Jun 10. No abstract available.

PMID:
26063638
40.

CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials.

Schulz KF, Altman DG, Moher D.

J Pharmacol Pharmacother. 2010 Jul;1(2):100-7. doi: 10.4103/0976-500X.72352. No abstract available.

41.

20 µg versus >20 µg estrogen combined oral contraceptives for contraception.

Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD003989. doi: 10.1002/14651858.CD003989.pub4. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD003989.

PMID:
21249657
42.

Describing reporting guidelines for health research: a systematic review.

Moher D, Weeks L, Ocampo M, Seely D, Sampson M, Altman DG, Schulz KF, Miller D, Simera I, Grimshaw J, Hoey J.

J Clin Epidemiol. 2011 Jul;64(7):718-42. doi: 10.1016/j.jclinepi.2010.09.013. Epub 2011 Jan 8. Review.

PMID:
21216130
43.

Nonspecific side effects of oral contraceptives: nocebo or noise?

Grimes DA, Schulz KF.

Contraception. 2011 Jan;83(1):5-9. doi: 10.1016/j.contraception.2010.06.010. Epub 2010 Aug 5.

PMID:
21134497
44.

CONSORT 2010 comments.

Schulz KF, Moher D, Altman DG.

Lancet. 2010 Oct 9;376(9748):1222-3. doi: 10.1016/S0140-6736(10)61879-X. No abstract available.

PMID:
20934594
45.

[CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (Chinese version)].

Schulz KF, Altman DG, Moher D; Consort Group.

Zhong Xi Yi Jie He Xue Bao. 2010 Jul;8(7):604-12. Chinese.

PMID:
20619135
46.

Development of a combined database for meta-epidemiological research.

Savović J, Harris RJ, Wood L, Beynon R, Altman D, Als-Nielsen B, Balk EM, Deeks J, Gluud LL, Gluud C, Ioannidis JP, Jűni P, Moher D, Pildal J, Schulz KF, Sterne JA.

Res Synth Methods. 2010 Jul;1(3-4):212-25. doi: 10.1002/jrsm.18. Epub 2010 Nov 30. Erratum in: Res Synth Methods. 2011 Mar;2(1):78.

PMID:
26061467
47.

Immediate postabortal insertion of intrauterine devices.

Grimes DA, Lopez LM, Schulz KF, Stanwood NL.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD001777. doi: 10.1002/14651858.CD001777.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD001777.

PMID:
20556754
48.

Immediate post-partum insertion of intrauterine devices.

Grimes DA, Lopez LM, Schulz KF, Van Vliet HA, Stanwood NL.

Cochrane Database Syst Rev. 2010 May 12;(5):CD003036. doi: 10.1002/14651858.CD003036.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;6:CD003036.

PMID:
20464722
49.

Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network.

Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG.

BMC Med. 2010 Apr 26;8:24. doi: 10.1186/1741-7015-8-24. Review.

50.

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

Schulz KF, Altman DG, Moher D; CONSORT Group.

Obstet Gynecol. 2010 May;115(5):1063-70. doi: 10.1097/AOG.0b013e3181d9d421. No abstract available.

PMID:
20410783

Supplemental Content

Loading ...
Support Center